We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
+12.64%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$3B
AUM Growth
+$175M
Cap. Flow
-$110M
Cap. Flow %
-3.66%
Top 10 Hldgs %
32.91%
Holding
863
New
116
Increased
124
Reduced
210
Closed
111

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$14.6M
2
OLN icon
Olin
OLN
+$13.5M
3
DKS icon
Dick's Sporting Goods
DKS
+$12.1M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$9.78M
5
DRI icon
Darden Restaurants
DRI
+$9.65M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$25.1M
2
LLY icon
Eli Lilly
LLY
+$17M
3
PG icon
Procter & Gamble
PG
+$14.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.5M
5
EBAY icon
eBay
EBAY
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 34.15%
2 Consumer Discretionary 18.06%
3 Healthcare 13.51%
4 Communication Services 9.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
426
Kura Oncology
KURA
$850M
$520K 0.02%
24,948
+60
+0.2% +$1.49K
REGN icon
427
Regeneron Pharmaceuticals
REGN
$80.8B
$514K 0.02%
919
– –
CWBC
428
Community West Bancshares
CWBC
$684M
$505K 0.02%
25,053
-18
-0.1% -$360
LLY icon
429
Eli Lilly
LLY
$1.06T
$505K 0.02%
2,200
-84,747
-97% -$17M
HOFT icon
430
Hooker Furnishings Corp
HOFT
$166M
$499K 0.02%
14,400
– –
VOXX
431
DELISTED
VOXX International Corporation Class A
VOXX
$498K 0.02%
35,500
– –
CBAY
432
DELISTED
Cymabay Therapeutics
CBAY
$498K 0.02%
114,200
– –
RRX icon
433
Regal Rexnord
RRX
$11.9B
$487K 0.02%
3,648
– –
CNXC icon
434
Concentrix
CNXC
$1.57B
$472K 0.02%
2,939
-5,424
-65% -$834K
EME icon
435
Emcor
EME
$36B
$464K 0.02%
3,763
– –
VRTX icon
436
Vertex Pharmaceuticals
VRTX
$126B
$464K 0.02%
2,300
-54,872
-96% -$11.5M
EGRX
437
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$463K 0.02%
10,813
+25
+0.2% +$1.03K
RJET
438
Republic Airways Holdings
RJET
$1B
$461K 0.02%
3,297
– –
BC icon
439
Brunswick
BC
$5.28B
$454K 0.02%
4,560
– –
PTCT icon
440
PTC Therapeutics
PTCT
$6.12B
$452K 0.02%
10,677
+26
+0.2% +$1.11K
RITM icon
441
Rithm Capital
RITM
$5.69B
$448K 0.01%
42,299
– –
ALLO icon
442
Allogene Therapeutics
ALLO
$694M
$447K 0.01%
17,108
+6,784
+66% +$193K
TPR icon
443
Tapestry
TPR
$32.8B
$446K 0.01%
10,255
+20
+0.2% +$893
NXPI icon
444
NXP Semiconductors
NXPI
$60.4B
$442K 0.01%
2,150
-4
-0.2% -$802
SLGN icon
445
Silgan Holdings
SLGN
$4.41B
$442K 0.01%
10,643
– –
SPT icon
446
Sprout Social
SPT
$621M
$426K 0.01%
+4,763
New +$330K
VIR icon
447
Vir Biotechnology
VIR
$1.49B
$420K 0.01%
8,896
+3
+0% +$136
LBTYK icon
448
Liberty Global Class C
LBTYK
$3.49B
$416K 0.01%
15,380
– –
RGNX icon
449
Regenxbio
RGNX
$708M
$400K 0.01%
10,311
+24
+0.2% +$858
KDMN
450
DELISTED
Kadmon Holdings, Inc.
KDMN
$398K 0.01%
103,044
-524,557
-84% -$2.03M
16 17
18
19 20

Similar funds

GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return
SEC
Seven Eight Capital New York $1.11B AUM 29.48% 1-Year Est. Return
AFG
Argent Financial Group Ruston, Louisiana $842M AUM
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return

ClariVest Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, ClariVest Asset Management held 863 positions worth $3B, up 6.2% from $2.83B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ClariVest Asset Management withdrew a net $110M in Q2 2021, closing 111 positions and reducing 210 holdings. Its most notable exit was Amgen, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, ClariVest Asset Management opened a new position in Charles Schwab worth $15M.

  • ClariVest Asset Management's largest Q2 2021 buy was Charles Schwab: 206,235 shares worth $15M.
  • ClariVest Asset Management added most to Olin in Q2 2021, an estimated $13.5M increase.
  • ClariVest Asset Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $17M.
  • ClariVest Asset Management fully exited Amgen in Q2 2021, selling an estimated $25.1M.
  • ClariVest Asset Management's ten largest holdings make up 33% of its $3B portfolio in Q2 2021.
  • ClariVest Asset Management opened 116 new positions and closed 111 in Q2 2021.
  • ClariVest Asset Management's portfolio value rose 6.2% quarter-over-quarter to $3B.

Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.